Patents by Inventor David John Parker

David John Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240390849
    Abstract: Increasing the pressure of a slurry by a filter press in which mineral oxide reacts with carbon dioxide enhances the formation of the carbonate by increasing the solubility and availability of carbon dioxide, accelerating reaction rates, shifting equilibria favorably, and promoting the formation of reaction intermediates like bicarbonate ions. A more efficient and faster synthesis of metal carbonates results.
    Type: Application
    Filed: May 31, 2024
    Publication date: November 28, 2024
    Applicant: KNUCO 1, LLC
    Inventors: David John Bower, Michael Henry Parker
  • Patent number: 12065650
    Abstract: Nodulisporic acids (NAs) comprise a group of indole diterpenes known for their potent insecticidal activities; however, biosynthesis of NAs by its natural producer, Hypoxylon pulicicidum (Nodulisporium sp.) is exceptionally difficult to achieve. The identification of genes responsible for NA production could enable biosynthetic pathway optimization to provide access to NAs for commercial applications. Obtaining useful quantities of NAs using published fermentations methods is challenging, making gene knockout studies an undesirable method to confirm gene function. Alternatively, heterologous gene expression of H. pulicicidum genes in a more robust host species like Penicillium paxilli provides a way to rapidly identify the function of genes that play a role in NA biosynthesis. In this work, we identified the function of four secondary-metabolic genes necessary for the biosynthesis of nodulisporic acid F (NAF) and reconstituted these genes in the genome of P.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: August 20, 2024
    Assignee: Massey University
    Inventors: Matthew Joseph Nicholson, Sarah Adeline Kessans, Emily Jane Parker, Leyla Yolanda Bustamante Rodriguez, David Barry Scott, Kyle Cornelius Van de Bittner, Craig John Van Dolleweerd
  • Publication number: 20140076575
    Abstract: A system for producing hydrocarbons from a subsea wellbore includes a primary conductor extending into the seabed. In addition, the system includes a wellhead disposed at an upper end of the primary conductor. Further, the system includes a multi bore tubing hanger seated in the wellhead. Still further, the system includes a production tree mounted to the wellhead. The production tree includes a spool body and a production spool extending radially from the spool body. The production spool has an end comprising a connector. Moreover, the system includes a rotatable production guide base coupled to the primary conductor and configured to rotate about the wellhead. The production guide base includes a rigid alignment spool. The alignment spool has a first end releasably coupled to the production spool, a second end comprising a second connector, and non-linear deviation positioned between the first end and the second end.
    Type: Application
    Filed: August 12, 2013
    Publication date: March 20, 2014
    Applicants: BP Exploration Operating Company Limited, BP CORPORATION NORTH AMERICA, INC.
    Inventors: Donald Graham Allan, David John Parker, Gregory Richard Blome
  • Patent number: 8536346
    Abstract: N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefore are prepared by new synthetic methods.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: September 17, 2013
    Assignee: Novartis AG
    Inventors: Murat Acemoglu, Joginder S. Bajwa, David John Parker, Joel Slade
  • Publication number: 20120010418
    Abstract: N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefore are prepared by new synthetic methods.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 12, 2012
    Applicant: NOVARTIS AG
    Inventors: Murat Acemoglu, Joginder S. Bajwa, David John Parker, Joel Slade
  • Patent number: 7989639
    Abstract: Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide are prepared by various methods.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: August 2, 2011
    Assignee: Novartis AG
    Inventors: Joginder S. Bajwa, David John Parker, Joel Slade
  • Publication number: 20090306405
    Abstract: N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor are prepared by new synthetic methods.
    Type: Application
    Filed: June 7, 2007
    Publication date: December 10, 2009
    Applicant: NOVARTIS AG
    Inventors: Murat Acemoglu, Joginder S. Bajwa, David John Parker, Joel Slade
  • Publication number: 20090187029
    Abstract: Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide are prepared by various methods.
    Type: Application
    Filed: June 7, 2007
    Publication date: July 23, 2009
    Inventors: Joginder S. Bajwa, David John Parker, Joel Slade
  • Publication number: 20090143469
    Abstract: The present invention relates to salts of organic acid, in particular salt of nateglinide, combined preparations comprising one or more salts of nateglinide and, optionally, one or more additional ingredients and the use thereof in pharmaceutical compositions for preventing or treating diabetes, cardiovascular disease, or conditions associated therewith.
    Type: Application
    Filed: February 6, 2009
    Publication date: June 4, 2009
    Inventors: Paul Allen Sutton, Richard V. Vivilecchia, David John Parker, Marilyn De La Cruz
  • Publication number: 20090118515
    Abstract: The present invention is directed to a process for preparing intermediates that are useful to prepare certain antibacterial N-formyl hydroxylamine compounds which are peptide deformylase inhibitors.
    Type: Application
    Filed: November 3, 2008
    Publication date: May 7, 2009
    Applicant: NOVARTIS AG
    Inventors: Joel SLADE, James Anthony VIVELO, Guang-Pei CHEN, Joginder Singh BAJWA, David John PARKER